Aseptically Prepared Systemic Anti-Cancer Therapy Medicines

This framework agreement is for the supply of a range of aseptically prepared, batch manufactured systemic anti-cancer therapy drugs in ready-to-administer presentations and agreed dose bands. The framework agreement will also cover the manufacturing and supply of patient specific systemic anti-cancer therapy drugs, CIVAs, and provisions for stock inventory management and supply of compounded systemic anti-cancer therapy.

This Lot will cover the requirements for dose banded aseptically prepared systemic anti-cancer therapy medicines for adult and paediatric patients that can be supplied in batch or single units, and in line with National Dose Banded Tables where a specification exists. This Lot will cover the requirements for Patient Specific aseptically prepared anti-cancer therapy medicines in adult and paediatric patients.

This Lot covers the requirements for medicines used in CIVAs, and includes any preparation of medicine which is manipulated aseptically to create ready-to-use injectable medicine. This Lot covers the requirement for storage, warehousing, stock inventory management and stocking a range of batch systemic anti-cancer therapy medicines readily available for next-day or named day delivery.